After administration of the selective OX1R antagonist, SB334867 (10 mg/kg)64, and selective OX2R antagonist, EMPA (10 mg/kg)36, we found that both compounds were able to reverse aberrant dopamine system function in our rodent model of PTSD and psychosis. The gene discussed is HCRTR2; the disease is psychotic disorder.